Drug intelligence / Profile preview

Pi Zheng

Development stage: Preclinical
Lead developer: Longhua Hospital Shanghai University of Traditional Chinese Medicine
Modality: Small Molecules
Administration: Oral

Overview

Pi Zheng is a traditional Chinese medicine formulation, presented as particles, currently being investigated for the treatment of cervical spondylosis. It is part of an integrative traditional Chinese and Western medicine therapy approach, aiming to optimize treatment outcomes for this condition.

Other names: Pi Zheng particles

Beyond the preview

Go deeper on Pi Zheng.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pi Zheng.

Explore the full profile